Measurement of human chylomicron triglyceride clearance with a labeled commercial lipid emulsion

Y. Park, B. D. Damron, J. M. Miles, William Harris

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Human chylomicron triglyceride (TG) kinetics has been difficult to determine directly owing to technical limitations. This report describes a new method for studying chylomicron metabolism. Healthy volunteers (n = 10) sipped a drink providing 175 mg fat·kg-1·h-1 for 7.5 h to produce a steady-state chylomicronemia. A commercial 10% intravenous lipid emulsion was labeled with [3H]triolein, purified by high-performance liquid chromatography, and sterilized. A trace amount of labeled emulsion was injected intravenously 30 min before (i.e., in the fasting state) and 5, 6, and 7 h after sipping began (i.e., triplicate determinations in the fed state). Chylomicron half-lives were calculated from the monoexponential decay curves, and apparent distribution volumes were estimated by back-extrapolation to time zero. Plasma and estimated chylomicron TG concentrations increased from 89 ± 13 and 0.8 ± 0.3 to 263 ± 43 and 91 ± 39 mg/dL (mean ± SEM), respectively, with feeding. Tracer-determined chylomicron TG half-lives were 5.34 ± 0.58 and 6.51 ± 0.58 min during the fasting and fed states, respectively (P <0.01). The apparent distribution volume during the fasting state was 24% greater than plasma volume (4515 ± 308 vs. 3630 ± 78 mL, P <0.02), consistent with significant margination of lipid emulsion particles to endothelial binding sites. Margination was reduced during the fed state, suggesting that native chylomicrons competed with lipid emulsion particles for endothelial lipoprotein lipase. The results indicate that a radiolabeled commercial lipid emulsion is metabolized in a fashion similar to native chylomicron TG, and thus can be used to study chylomicron TG kinetics.

Original languageEnglish (US)
Pages (from-to)115-120
Number of pages6
JournalLipids
Volume36
Issue number2
StatePublished - 2001
Externally publishedYes

Fingerprint

Chylomicrons
chylomicrons
Emulsions
emulsions
Triglycerides
triacylglycerols
Lipids
lipids
fasting
Fasting
half life
Intravenous Fat Emulsions
Triolein
Plasmas
kinetics
triolein
Kinetics
lipoprotein lipase
Lipoprotein Lipase
Plasma Volume

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Food Science
  • Biochemistry

Cite this

Park, Y., Damron, B. D., Miles, J. M., & Harris, W. (2001). Measurement of human chylomicron triglyceride clearance with a labeled commercial lipid emulsion. Lipids, 36(2), 115-120.

Measurement of human chylomicron triglyceride clearance with a labeled commercial lipid emulsion. / Park, Y.; Damron, B. D.; Miles, J. M.; Harris, William.

In: Lipids, Vol. 36, No. 2, 2001, p. 115-120.

Research output: Contribution to journalArticle

Park, Y, Damron, BD, Miles, JM & Harris, W 2001, 'Measurement of human chylomicron triglyceride clearance with a labeled commercial lipid emulsion', Lipids, vol. 36, no. 2, pp. 115-120.
Park, Y. ; Damron, B. D. ; Miles, J. M. ; Harris, William. / Measurement of human chylomicron triglyceride clearance with a labeled commercial lipid emulsion. In: Lipids. 2001 ; Vol. 36, No. 2. pp. 115-120.
@article{3407507abc404937943a28fbcc028f75,
title = "Measurement of human chylomicron triglyceride clearance with a labeled commercial lipid emulsion",
abstract = "Human chylomicron triglyceride (TG) kinetics has been difficult to determine directly owing to technical limitations. This report describes a new method for studying chylomicron metabolism. Healthy volunteers (n = 10) sipped a drink providing 175 mg fat·kg-1·h-1 for 7.5 h to produce a steady-state chylomicronemia. A commercial 10{\%} intravenous lipid emulsion was labeled with [3H]triolein, purified by high-performance liquid chromatography, and sterilized. A trace amount of labeled emulsion was injected intravenously 30 min before (i.e., in the fasting state) and 5, 6, and 7 h after sipping began (i.e., triplicate determinations in the fed state). Chylomicron half-lives were calculated from the monoexponential decay curves, and apparent distribution volumes were estimated by back-extrapolation to time zero. Plasma and estimated chylomicron TG concentrations increased from 89 ± 13 and 0.8 ± 0.3 to 263 ± 43 and 91 ± 39 mg/dL (mean ± SEM), respectively, with feeding. Tracer-determined chylomicron TG half-lives were 5.34 ± 0.58 and 6.51 ± 0.58 min during the fasting and fed states, respectively (P <0.01). The apparent distribution volume during the fasting state was 24{\%} greater than plasma volume (4515 ± 308 vs. 3630 ± 78 mL, P <0.02), consistent with significant margination of lipid emulsion particles to endothelial binding sites. Margination was reduced during the fed state, suggesting that native chylomicrons competed with lipid emulsion particles for endothelial lipoprotein lipase. The results indicate that a radiolabeled commercial lipid emulsion is metabolized in a fashion similar to native chylomicron TG, and thus can be used to study chylomicron TG kinetics.",
author = "Y. Park and Damron, {B. D.} and Miles, {J. M.} and William Harris",
year = "2001",
language = "English (US)",
volume = "36",
pages = "115--120",
journal = "Lipids",
issn = "0024-4201",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Measurement of human chylomicron triglyceride clearance with a labeled commercial lipid emulsion

AU - Park, Y.

AU - Damron, B. D.

AU - Miles, J. M.

AU - Harris, William

PY - 2001

Y1 - 2001

N2 - Human chylomicron triglyceride (TG) kinetics has been difficult to determine directly owing to technical limitations. This report describes a new method for studying chylomicron metabolism. Healthy volunteers (n = 10) sipped a drink providing 175 mg fat·kg-1·h-1 for 7.5 h to produce a steady-state chylomicronemia. A commercial 10% intravenous lipid emulsion was labeled with [3H]triolein, purified by high-performance liquid chromatography, and sterilized. A trace amount of labeled emulsion was injected intravenously 30 min before (i.e., in the fasting state) and 5, 6, and 7 h after sipping began (i.e., triplicate determinations in the fed state). Chylomicron half-lives were calculated from the monoexponential decay curves, and apparent distribution volumes were estimated by back-extrapolation to time zero. Plasma and estimated chylomicron TG concentrations increased from 89 ± 13 and 0.8 ± 0.3 to 263 ± 43 and 91 ± 39 mg/dL (mean ± SEM), respectively, with feeding. Tracer-determined chylomicron TG half-lives were 5.34 ± 0.58 and 6.51 ± 0.58 min during the fasting and fed states, respectively (P <0.01). The apparent distribution volume during the fasting state was 24% greater than plasma volume (4515 ± 308 vs. 3630 ± 78 mL, P <0.02), consistent with significant margination of lipid emulsion particles to endothelial binding sites. Margination was reduced during the fed state, suggesting that native chylomicrons competed with lipid emulsion particles for endothelial lipoprotein lipase. The results indicate that a radiolabeled commercial lipid emulsion is metabolized in a fashion similar to native chylomicron TG, and thus can be used to study chylomicron TG kinetics.

AB - Human chylomicron triglyceride (TG) kinetics has been difficult to determine directly owing to technical limitations. This report describes a new method for studying chylomicron metabolism. Healthy volunteers (n = 10) sipped a drink providing 175 mg fat·kg-1·h-1 for 7.5 h to produce a steady-state chylomicronemia. A commercial 10% intravenous lipid emulsion was labeled with [3H]triolein, purified by high-performance liquid chromatography, and sterilized. A trace amount of labeled emulsion was injected intravenously 30 min before (i.e., in the fasting state) and 5, 6, and 7 h after sipping began (i.e., triplicate determinations in the fed state). Chylomicron half-lives were calculated from the monoexponential decay curves, and apparent distribution volumes were estimated by back-extrapolation to time zero. Plasma and estimated chylomicron TG concentrations increased from 89 ± 13 and 0.8 ± 0.3 to 263 ± 43 and 91 ± 39 mg/dL (mean ± SEM), respectively, with feeding. Tracer-determined chylomicron TG half-lives were 5.34 ± 0.58 and 6.51 ± 0.58 min during the fasting and fed states, respectively (P <0.01). The apparent distribution volume during the fasting state was 24% greater than plasma volume (4515 ± 308 vs. 3630 ± 78 mL, P <0.02), consistent with significant margination of lipid emulsion particles to endothelial binding sites. Margination was reduced during the fed state, suggesting that native chylomicrons competed with lipid emulsion particles for endothelial lipoprotein lipase. The results indicate that a radiolabeled commercial lipid emulsion is metabolized in a fashion similar to native chylomicron TG, and thus can be used to study chylomicron TG kinetics.

UR - http://www.scopus.com/inward/record.url?scp=0035106627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035106627&partnerID=8YFLogxK

M3 - Article

C2 - 11269690

AN - SCOPUS:0035106627

VL - 36

SP - 115

EP - 120

JO - Lipids

JF - Lipids

SN - 0024-4201

IS - 2

ER -